Can Alcohol Dependent Patients Adhere to an ‘As-Needed' Medication Regimen?
- 15 February 2014
- journal article
- research article
- Published by S. Karger AG in European Addiction Research
- Vol. 20 (5), 209-217
- https://doi.org/10.1159/000357865
Abstract
A pooled analysis of ‘as-needed medication use' data from 1,276 patients in two randomised, double-blind, placebo-controlled, parallel-group trials of nalmefene in the treatment of alcohol dependence was performed to explore whether an ‘as-needed' regimen is an acceptable and feasible strategy in patients seeking help for alcohol dependence. Adherence was defined as alcohol consumption and medication intake, or no alcohol consumption (with or without medication intake). Nalmefene was taken on approximately half of the study days; placebo was taken more often than nalmefene (52.8 vs. 64.5% of days, respectively). In each treatment group medication intake appeared to vary according to patients' needs in that intake correlated with the baseline drinking pattern. Sixty-eight percent of the nalmefene-treated patients (78% of the study completers) adhered to the as-needed treatment regimen on at least 80% of the study days. In conclusion, as-needed use is a feasible, patient-centred approach that engages patients with alcohol dependence in the active management of their illness.Keywords
This publication has 30 references indexed in Scilit:
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month StudiesAlcohol and Alcoholism, 2013
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed NalmefeneBiological Psychiatry, 2013
- Posttreatment Low-Risk Drinking as a Predictor of Future Drinking and Problem Outcomes Among Individuals with Alcohol Use DisordersAlcohol: Clinical and Experimental Research, 2012
- Do patient autonomy preferences matter? Linking patient-centered care to patient–physician relationships and health outcomesSocial Science & Medicine (1982), 2010
- Acamprosate for alcohol dependenceEmergencias, 2010
- Targeted Naltrexone for Problem DrinkersJournal of Clinical Psychopharmacology, 2009
- A pilot study of naltrexone and BASICS for heavy drinking young adultsAddictive Behaviors, 2008
- Targeted Nalmefene With Simple Medical Management in the Treatment of Heavy Drinkers: A Randomized Double‐Blind Placebo‐Controlled Multicenter StudyAlcohol: Clinical and Experimental Research, 2007
- Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity?Neuropsychopharmacology, 2005
- A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol DependenceAlcohol: Clinical and Experimental Research, 1994